restor3d Completes Acquisition of Conformis
DURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023.
- DURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023.
- In connection with the completion of the acquisition, shares of Conformis’ common stock ceased trading on the NASDAQ prior to the opening of the NASDAQ on September 5, 2023.
- “We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body,” said J. Kurt Jacobus, CEO of restor3d.
- With existing expertise in 3D printing of osseointegrative biomedical materials, biomechanics modeling, artificial-intelligence-based planning and design automation tools, the addition of Conformis propels the scalable future of best-in-class personalized device solutions to present day.